Borosil Scientific Q2 Profit Up 86% on Strategic Growth Plan

Net Sales: Rs 115.0 Cr (+7.5% YoY) | PAT: Rs 5.3 Cr (+86.3% YoY)

Reader Takeaway: Strong operational recovery supported by subsidiary performance, though standalone margins remain sensitive to input cost volatility.

What just happened

Borosil Scientific released its Q2 FY27 results, showcasing significant growth in profitability despite a challenging global supply chain environment. The company's net sales reached Rs 115 crore, while EBITDA improved by nearly 30% to Rs 11 crore compared to the same period last year. Profit after tax saw a sharp uptick of 86.3%, landing at Rs 5.3 crore.

Why this matters

The results highlight the turnaround of the subsidiary, Goel Glass Works Scientific Limited, which saw sales grow by 28.7%. More importantly, the management has signaled aggressive growth with a Rs 130 crore capex program designed to scale glassware production from 15 lakh units annually to 108 lakh units by 2027. This move, combined with a new glass tubing furnace, is expected to reduce import dependency and secure the supply chain.

Strategic Goals

The company is targeting a 12-14% revenue CAGR. Future margin expansion is tied to a shift toward high-margin segments like Process Sciences and Lab Equipment. Management is also banking on manufacturing optimization to cushion against the current input cost pressures.

Risks to watch

Standalone profitability was hindered this quarter by rising input costs stemming from Middle East geopolitical tensions. Furthermore, the Rs 130 crore capital expenditure plan spans multiple years, exposing shareholders to typical execution and project-timeline risks. Investors should monitor how effectively the company maintains margins while absorbing these heavy investments.